The global Advanced Drug Delivery market size was valued at USD 5379.4 million in 2023 and is forecast to a readjusted size of USD 16930 million by 2030 with a CAGR of 17.8% during review period.
Advanced Drug Delivery refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the Advanced Drug Delivery industry chain, the market status of Hospitals (Polymeric Drug Delivery, Implants & IUD's), Diagnostic Centers (Polymeric Drug Delivery, Implants & IUD's), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Advanced Drug Delivery.
Regionally, the report analyzes the Advanced Drug Delivery markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Advanced Drug Delivery market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Advanced Drug Delivery market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Advanced Drug Delivery industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Polymeric Drug Delivery, Implants & IUD's).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Advanced Drug Delivery market.
Regional Analysis: The report involves examining the Advanced Drug Delivery market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Advanced Drug Delivery market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Advanced Drug Delivery:
Company Analysis: Report covers individual Advanced Drug Delivery players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Advanced Drug Delivery This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to Advanced Drug Delivery. It assesses the current state, advancements, and potential future developments in Advanced Drug Delivery areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Advanced Drug Delivery market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Advanced Drug Delivery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Market segment by Application
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
Market segment by players, this report covers
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Advanced Drug Delivery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Advanced Drug Delivery, with revenue, gross margin and global market share of Advanced Drug Delivery from 2019 to 2024.
Chapter 3, the Advanced Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Advanced Drug Delivery market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Advanced Drug Delivery.
Chapter 13, to describe Advanced Drug Delivery research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Advanced Drug Delivery
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Advanced Drug Delivery by Type
1.3.1 Overview: Global Advanced Drug Delivery Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Advanced Drug Delivery Consumption Value Market Share by Type in 2023
1.3.3 Polymeric Drug Delivery
1.3.4 Implants & IUD's
1.3.5 Sustained Release
1.3.6 Targeted Drug Delivery
1.3.7 Prodrugs
1.4 Global Advanced Drug Delivery Market by Application
1.4.1 Overview: Global Advanced Drug Delivery Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Diagnostic Centers
1.4.4 Ambulatory Surgical Centers/Clinics
1.4.5 Home Care Settings
1.4.6 Other End Users
1.5 Global Advanced Drug Delivery Market Size & Forecast
1.6 Global Advanced Drug Delivery Market Size and Forecast by Region
1.6.1 Global Advanced Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Advanced Drug Delivery Market Size by Region, (2019-2030)
1.6.3 North America Advanced Drug Delivery Market Size and Prospect (2019-2030)
1.6.4 Europe Advanced Drug Delivery Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Advanced Drug Delivery Market Size and Prospect (2019-2030)
1.6.6 South America Advanced Drug Delivery Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Advanced Drug Delivery Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Merck & Co
2.1.1 Merck & Co Details
2.1.2 Merck & Co Major Business
2.1.3 Merck & Co Advanced Drug Delivery Product and Solutions
2.1.4 Merck & Co Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck & Co Recent Developments and Future Plans
2.2 Antares Pharma
2.2.1 Antares Pharma Details
2.2.2 Antares Pharma Major Business
2.2.3 Antares Pharma Advanced Drug Delivery Product and Solutions
2.2.4 Antares Pharma Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Antares Pharma Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business
2.3.3 F. Hoffmann-La Roche Advanced Drug Delivery Product and Solutions
2.3.4 F. Hoffmann-La Roche Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Advanced Drug Delivery Product and Solutions
2.4.4 Novartis Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Advanced Drug Delivery Product and Solutions
2.5.4 Bayer Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bayer Recent Developments and Future Plans
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Advanced Drug Delivery Product and Solutions
2.6.4 Sanofi Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sanofi Recent Developments and Future Plans
2.7 Glaxosmithkline
2.7.1 Glaxosmithkline Details
2.7.2 Glaxosmithkline Major Business
2.7.3 Glaxosmithkline Advanced Drug Delivery Product and Solutions
2.7.4 Glaxosmithkline Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Glaxosmithkline Recent Developments and Future Plans
2.8 3M
2.8.1 3M Details
2.8.2 3M Major Business
2.8.3 3M Advanced Drug Delivery Product and Solutions
2.8.4 3M Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 3M Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Advanced Drug Delivery Product and Solutions
2.9.4 Pfizer Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Advanced Drug Delivery Product and Solutions
2.10.4 Johnson & Johnson Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
2.11 Abbott Laboratories
2.11.1 Abbott Laboratories Details
2.11.2 Abbott Laboratories Major Business
2.11.3 Abbott Laboratories Advanced Drug Delivery Product and Solutions
2.11.4 Abbott Laboratories Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Abbott Laboratories Recent Developments and Future Plans
2.12 Allergan
2.12.1 Allergan Details
2.12.2 Allergan Major Business
2.12.3 Allergan Advanced Drug Delivery Product and Solutions
2.12.4 Allergan Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Allergan Recent Developments and Future Plans
2.13 Baxter International
2.13.1 Baxter International Details
2.13.2 Baxter International Major Business
2.13.3 Baxter International Advanced Drug Delivery Product and Solutions
2.13.4 Baxter International Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Baxter International Recent Developments and Future Plans
2.14 Mylan Pharmaceutical
2.14.1 Mylan Pharmaceutical Details
2.14.2 Mylan Pharmaceutical Major Business
2.14.3 Mylan Pharmaceutical Advanced Drug Delivery Product and Solutions
2.14.4 Mylan Pharmaceutical Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Mylan Pharmaceutical Recent Developments and Future Plans
2.15 Roche Holding
2.15.1 Roche Holding Details
2.15.2 Roche Holding Major Business
2.15.3 Roche Holding Advanced Drug Delivery Product and Solutions
2.15.4 Roche Holding Advanced Drug Delivery Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Roche Holding Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Advanced Drug Delivery Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Advanced Drug Delivery by Company Revenue
3.2.2 Top 3 Advanced Drug Delivery Players Market Share in 2023
3.2.3 Top 6 Advanced Drug Delivery Players Market Share in 2023
3.3 Advanced Drug Delivery Market: Overall Company Footprint Analysis
3.3.1 Advanced Drug Delivery Market: Region Footprint
3.3.2 Advanced Drug Delivery Market: Company Product Type Footprint
3.3.3 Advanced Drug Delivery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Advanced Drug Delivery Consumption Value and Market Share by Type (2019-2024)
4.2 Global Advanced Drug Delivery Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Advanced Drug Delivery Consumption Value Market Share by Application (2019-2024)
5.2 Global Advanced Drug Delivery Market Forecast by Application (2025-2030)
6 North America
6.1 North America Advanced Drug Delivery Consumption Value by Type (2019-2030)
6.2 North America Advanced Drug Delivery Consumption Value by Application (2019-2030)
6.3 North America Advanced Drug Delivery Market Size by Country
6.3.1 North America Advanced Drug Delivery Consumption Value by Country (2019-2030)
6.3.2 United States Advanced Drug Delivery Market Size and Forecast (2019-2030)
6.3.3 Canada Advanced Drug Delivery Market Size and Forecast (2019-2030)
6.3.4 Mexico Advanced Drug Delivery Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Advanced Drug Delivery Consumption Value by Type (2019-2030)
7.2 Europe Advanced Drug Delivery Consumption Value by Application (2019-2030)
7.3 Europe Advanced Drug Delivery Market Size by Country
7.3.1 Europe Advanced Drug Delivery Consumption Value by Country (2019-2030)
7.3.2 Germany Advanced Drug Delivery Market Size and Forecast (2019-2030)
7.3.3 France Advanced Drug Delivery Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Advanced Drug Delivery Market Size and Forecast (2019-2030)
7.3.5 Russia Advanced Drug Delivery Market Size and Forecast (2019-2030)
7.3.6 Italy Advanced Drug Delivery Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Advanced Drug Delivery Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Advanced Drug Delivery Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Advanced Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Advanced Drug Delivery Consumption Value by Region (2019-2030)
8.3.2 China Advanced Drug Delivery Market Size and Forecast (2019-2030)
8.3.3 Japan Advanced Drug Delivery Market Size and Forecast (2019-2030)
8.3.4 South Korea Advanced Drug Delivery Market Size and Forecast (2019-2030)
8.3.5 India Advanced Drug Delivery Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Advanced Drug Delivery Market Size and Forecast (2019-2030)
8.3.7 Australia Advanced Drug Delivery Market Size and Forecast (2019-2030)
9 South America
9.1 South America Advanced Drug Delivery Consumption Value by Type (2019-2030)
9.2 South America Advanced Drug Delivery Consumption Value by Application (2019-2030)
9.3 South America Advanced Drug Delivery Market Size by Country
9.3.1 South America Advanced Drug Delivery Consumption Value by Country (2019-2030)
9.3.2 Brazil Advanced Drug Delivery Market Size and Forecast (2019-2030)
9.3.3 Argentina Advanced Drug Delivery Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Advanced Drug Delivery Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Advanced Drug Delivery Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Advanced Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Advanced Drug Delivery Consumption Value by Country (2019-2030)
10.3.2 Turkey Advanced Drug Delivery Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Advanced Drug Delivery Market Size and Forecast (2019-2030)
10.3.4 UAE Advanced Drug Delivery Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Advanced Drug Delivery Market Drivers
11.2 Advanced Drug Delivery Market Restraints
11.3 Advanced Drug Delivery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Advanced Drug Delivery Industry Chain
12.2 Advanced Drug Delivery Upstream Analysis
12.3 Advanced Drug Delivery Midstream Analysis
12.4 Advanced Drug Delivery Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
听
听
*If Applicable.